A critical assessment of officially reported chagas disease surveillance data in Mexico

Ellen M. Shelly, Rodolfo Acuna-Soto, Kacey C Ernst, Charles R Sterling, Heidi E Brown

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective. Chagas disease, a disease caused by Trypanosoma cruzi, disproportionately affects poor people throughout Latin America. In Mexico, assessments of officially reported burden have not been previously reported. To evaluate discontinuity between surveillance data and data from other sources, we used data from the Mexican Ministry of Health to describe the distribution of reported Chagas disease over time in Mexico and compare it with estimates from the literature. Methods. We summarized age and sex differences for Chagas cases and mortality for 1995–2013 and 1982–2010, respectively. We examined the spatial distribution of Chagas disease over time with respect to disease burden. We further compared officially reported figures with estimates from the literature. Results. Among 6,494 officially reported cases, rates of Chagas disease were highest in adults aged 25–44 years (47.3%). Mortality was highest in adults aged $45 years (423/495, 85.5%). The data indicated increasing temporal trends for incidence and mortality. The greatest burden occurred in southern states, with increasing spatial distribution over time. Fewer than 900 cases and 40 deaths were officially reported annually, in contrast to estimates from the literature of approximately 69,000 new cases and 25,000 deaths annually. Conclusion. While increasing trends in officially reported data have been observed, large discrepancies in case estimates compromise our understanding of Chagas disease epidemiology. Reported cases based on current practices are not enough to correctly assess the Chagas disease burden and spatial distribution in Mexico. Understanding the true epidemiology of this disease will lead to more focused and successful control and prevention strategies to decrease disease burden.

Original languageEnglish (US)
Pages (from-to)59-66
Number of pages8
JournalPublic Health Reports
Volume131
Issue number1
StatePublished - Jan 1 2016

Fingerprint

Chagas Disease
Mexico
Mortality
Epidemiology
Latin America
Trypanosoma cruzi
Information Storage and Retrieval
Sex Characteristics
Incidence
Health

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

A critical assessment of officially reported chagas disease surveillance data in Mexico. / Shelly, Ellen M.; Acuna-Soto, Rodolfo; Ernst, Kacey C; Sterling, Charles R; Brown, Heidi E.

In: Public Health Reports, Vol. 131, No. 1, 01.01.2016, p. 59-66.

Research output: Contribution to journalArticle

@article{3ec17c35c0024ee2857575a07fa312a7,
title = "A critical assessment of officially reported chagas disease surveillance data in Mexico",
abstract = "Objective. Chagas disease, a disease caused by Trypanosoma cruzi, disproportionately affects poor people throughout Latin America. In Mexico, assessments of officially reported burden have not been previously reported. To evaluate discontinuity between surveillance data and data from other sources, we used data from the Mexican Ministry of Health to describe the distribution of reported Chagas disease over time in Mexico and compare it with estimates from the literature. Methods. We summarized age and sex differences for Chagas cases and mortality for 1995–2013 and 1982–2010, respectively. We examined the spatial distribution of Chagas disease over time with respect to disease burden. We further compared officially reported figures with estimates from the literature. Results. Among 6,494 officially reported cases, rates of Chagas disease were highest in adults aged 25–44 years (47.3{\%}). Mortality was highest in adults aged $45 years (423/495, 85.5{\%}). The data indicated increasing temporal trends for incidence and mortality. The greatest burden occurred in southern states, with increasing spatial distribution over time. Fewer than 900 cases and 40 deaths were officially reported annually, in contrast to estimates from the literature of approximately 69,000 new cases and 25,000 deaths annually. Conclusion. While increasing trends in officially reported data have been observed, large discrepancies in case estimates compromise our understanding of Chagas disease epidemiology. Reported cases based on current practices are not enough to correctly assess the Chagas disease burden and spatial distribution in Mexico. Understanding the true epidemiology of this disease will lead to more focused and successful control and prevention strategies to decrease disease burden.",
author = "Shelly, {Ellen M.} and Rodolfo Acuna-Soto and Ernst, {Kacey C} and Sterling, {Charles R} and Brown, {Heidi E}",
year = "2016",
month = "1",
day = "1",
language = "English (US)",
volume = "131",
pages = "59--66",
journal = "Public Health Reports",
issn = "0033-3549",
publisher = "Association of Schools of Public Health",
number = "1",

}

TY - JOUR

T1 - A critical assessment of officially reported chagas disease surveillance data in Mexico

AU - Shelly, Ellen M.

AU - Acuna-Soto, Rodolfo

AU - Ernst, Kacey C

AU - Sterling, Charles R

AU - Brown, Heidi E

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Objective. Chagas disease, a disease caused by Trypanosoma cruzi, disproportionately affects poor people throughout Latin America. In Mexico, assessments of officially reported burden have not been previously reported. To evaluate discontinuity between surveillance data and data from other sources, we used data from the Mexican Ministry of Health to describe the distribution of reported Chagas disease over time in Mexico and compare it with estimates from the literature. Methods. We summarized age and sex differences for Chagas cases and mortality for 1995–2013 and 1982–2010, respectively. We examined the spatial distribution of Chagas disease over time with respect to disease burden. We further compared officially reported figures with estimates from the literature. Results. Among 6,494 officially reported cases, rates of Chagas disease were highest in adults aged 25–44 years (47.3%). Mortality was highest in adults aged $45 years (423/495, 85.5%). The data indicated increasing temporal trends for incidence and mortality. The greatest burden occurred in southern states, with increasing spatial distribution over time. Fewer than 900 cases and 40 deaths were officially reported annually, in contrast to estimates from the literature of approximately 69,000 new cases and 25,000 deaths annually. Conclusion. While increasing trends in officially reported data have been observed, large discrepancies in case estimates compromise our understanding of Chagas disease epidemiology. Reported cases based on current practices are not enough to correctly assess the Chagas disease burden and spatial distribution in Mexico. Understanding the true epidemiology of this disease will lead to more focused and successful control and prevention strategies to decrease disease burden.

AB - Objective. Chagas disease, a disease caused by Trypanosoma cruzi, disproportionately affects poor people throughout Latin America. In Mexico, assessments of officially reported burden have not been previously reported. To evaluate discontinuity between surveillance data and data from other sources, we used data from the Mexican Ministry of Health to describe the distribution of reported Chagas disease over time in Mexico and compare it with estimates from the literature. Methods. We summarized age and sex differences for Chagas cases and mortality for 1995–2013 and 1982–2010, respectively. We examined the spatial distribution of Chagas disease over time with respect to disease burden. We further compared officially reported figures with estimates from the literature. Results. Among 6,494 officially reported cases, rates of Chagas disease were highest in adults aged 25–44 years (47.3%). Mortality was highest in adults aged $45 years (423/495, 85.5%). The data indicated increasing temporal trends for incidence and mortality. The greatest burden occurred in southern states, with increasing spatial distribution over time. Fewer than 900 cases and 40 deaths were officially reported annually, in contrast to estimates from the literature of approximately 69,000 new cases and 25,000 deaths annually. Conclusion. While increasing trends in officially reported data have been observed, large discrepancies in case estimates compromise our understanding of Chagas disease epidemiology. Reported cases based on current practices are not enough to correctly assess the Chagas disease burden and spatial distribution in Mexico. Understanding the true epidemiology of this disease will lead to more focused and successful control and prevention strategies to decrease disease burden.

UR - http://www.scopus.com/inward/record.url?scp=84953212633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953212633&partnerID=8YFLogxK

M3 - Article

C2 - 26843671

AN - SCOPUS:84953212633

VL - 131

SP - 59

EP - 66

JO - Public Health Reports

JF - Public Health Reports

SN - 0033-3549

IS - 1

ER -